Logo image of CLNC

Colony Northstar Credit Real Estate Inc Class (CLNC) Stock Fundamental Analysis

NYSE:CLNC - New York Stock Exchange, Inc. -

10.32  +0.16 (+1.57%)

After market: 10.32 0 (0%)

Fundamental Rating

1

Overall CLNC gets a fundamental rating of 1 out of 10. We evaluated CLNC against 64 industry peers in the Mortgage Real Estate Investment Trusts (REITs)" industry. CLNC has a bad profitability rating. Also its financial health evaluation is rather negative. CLNC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CLNC had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -5.93%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -57.18%
PM (TTM) -153.23%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

1

2. Health

2.1 Basic Checks

CLNC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

CLNC has a Debt/Equity ratio of 0.88. This is a neutral value indicating CLNC is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

2

3. Growth

3.1 Past

CLNC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -35.21%.
Measured over the past years, CLNC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.13% on average per year.
Looking at the last year, CLNC shows a very negative growth in Revenue. The Revenue has decreased by -33.21% in the last year.
The Revenue has been growing by 19.89% on average over the past years. This is quite good.
EPS 1Y (TTM)-35.21%
EPS 3Y14.13%
EPS 5YN/A
EPS Q2Q%-84.13%
Revenue 1Y (TTM)-33.21%
Revenue growth 3Y24.77%
Revenue growth 5Y19.89%
Sales Q2Q%-44.31%

3.2 Future

CLNC is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -60.26% yearly.
The Revenue is expected to decrease by -23.37% on average over the next years. This is quite bad
EPS Next Y-34.75%
EPS Next 2Y-2.47%
EPS Next 3Y-46.57%
EPS Next 5Y-60.26%
Revenue Next Year-20.54%
Revenue Next 2Y-22.96%
Revenue Next 3Y-23.37%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CLNC Yearly Revenue VS EstimatesCLNC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
CLNC Yearly EPS VS EstimatesCLNC Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 0 0.5 -0.5 1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 22.43, the valuation of CLNC can be described as rather expensive.
Compared to an average S&P500 Price/Earnings ratio of 29.53, CLNC is valued a bit cheaper.
With a Price/Forward Earnings ratio of 10.96, the valuation of CLNC can be described as very reasonable.
CLNC's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.65.
Industry RankSector Rank
PE 22.43
Fwd PE 10.96
CLNC Price Earnings VS Forward Price EarningsCLNC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -26.24
CLNC Per share dataCLNC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

A cheap valuation may be justified as CLNC's earnings are expected to decrease with -46.57% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.47%
EPS Next 3Y-46.57%

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.43%, CLNC is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.27, CLNC pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.43%

5.2 History

The dividend of CLNC decreases each year by -29.45%.
CLNC has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)-29.45%
Div Incr YearsN/A
Div Non Decr YearsN/A
CLNC Yearly Dividends per shareCLNC Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 0.5 1 1.5

5.3 Sustainability

The earnings of CLNC are negative and hence is the payout ratio. CLNC will probably not be able to sustain this dividend level.
CLNC's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP-3.58%
EPS Next 2Y-2.47%
EPS Next 3Y-46.57%

More info and screens

Colony Northstar Credit Real Estate Inc Class

NYSE:CLNC (6/24/2021, 8:04:00 PM)

After market: 10.32 0 (0%)

10.32

+0.16 (+1.57%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.02%
Inst Owner Change-80.04%
Ins Owners0.33%
Ins Owner Change0%
Market Cap1.34B
Analysts73.4
Price Target12.24 (18.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.43%
Yearly Dividend0.56
Dividend Growth(5Y)-29.45%
DP-3.58%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 22.43
Fwd PE 10.96
P/S 5.59
P/FCF N/A
P/OCF N/A
P/B 0.73
P/tB N/A
EV/EBITDA -26.24
EPS(TTM)0.46
EY4.46%
EPS(NY)0.94
Fwd EY9.13%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.85
BVpS14.15
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.93%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -57.18%
PM (TTM) -153.23%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.21%
EPS 3Y14.13%
EPS 5YN/A
EPS Q2Q%-84.13%
EPS Next Y-34.75%
EPS Next 2Y-2.47%
EPS Next 3Y-46.57%
EPS Next 5Y-60.26%
Revenue 1Y (TTM)-33.21%
Revenue growth 3Y24.77%
Revenue growth 5Y19.89%
Sales Q2Q%-44.31%
Revenue Next Year-20.54%
Revenue Next 2Y-22.96%
Revenue Next 3Y-23.37%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A